Storia in 3 fonti

Natco Pharma’s Q4 net down 34% at ₹269 cr

Natco Pharma reports a 34% drop in Q4 net profit to Rs 269 crore, citing revenue decline and price erosion.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

thehindu.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo3 mesi fa

Natco Pharma’s Q4 net down 34% at ₹269 cr

Natco Pharma reports a 34% drop in Q4 net profit to Rs 269 crore, citing revenue decline and price erosion.

originale

thehindu.com3 mesi fa

Natco Pharma Q4 net slips 34% to ₹269 cr. on formulation exports, shares fall 13.5%

Natco Pharma reported consolidated net profit for the March quarter declined nearly 34% to ₹269 crore compared with the ₹406 crore a year earlier on the back of a sharp fall in revenue from formulations export.

Leggi questa versione → originale

Timeline cronologica

venerdì 29 maggio 2026·economictimes.indiatimes.com
Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY
Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins and lower annual earnings weighed on…
venerdì 29 maggio 2026·thehindubusinessline.com
Natco Pharma’s Q4 net down 34% at ₹269 cr
Natco Pharma reports a 34% drop in Q4 net profit to Rs 269 crore, citing revenue decline and price erosion.

Natco Pharma’s Q4 net down 34% at ₹269 cr

Natco Pharma Q4 net slips 34% to ₹269 cr. on formulation exports, shares fall 13.5%

Timeline cronologica

Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY

Natco Pharma’s Q4 net down 34% at ₹269 cr

Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY

Natco Pharma Q4 net slips 34% to ₹269 cr. on formulation exports, shares fall 13.5%